ENOV
Price
$26.25
Change
+$0.50 (+1.94%)
Updated
Jul 13 closing price
Capitalization
1.51B
16 days until earnings call
Intraday BUY SELL Signals
SIBN
Price
$17.85
Change
+$0.29 (+1.65%)
Updated
Jul 13 closing price
Capitalization
791.19M
27 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ENOV vs SIBN

ENOV vs SIBN Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ENOV vs. SIBN commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENOV is a StrongBuy and SIBN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2026
Stock price -- (ENOV: $26.25 vs. SIBN: $17.85)
Brand notoriety: ENOV and SIBN are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: ENOV: 74% vs. SIBN: 33%
Market capitalization -- ENOV: $1.51B vs. SIBN: $791.19M
ENOV [@Medical/Nursing Services] is valued at $1.51B. SIBN’s [@Medical/Nursing Services] market capitalization is $791.19M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $160.44B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.64B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENOV’s FA Score shows that 0 FA rating(s) are green whileSIBN’s FA Score has 0 green FA rating(s).

  • ENOV’s FA Score: 0 green, 5 red.
  • SIBN’s FA Score: 0 green, 5 red.
According to our system of comparison, SIBN is a better buy in the long-term than ENOV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENOV’s TA Score shows that 5 TA indicator(s) are bullish while SIBN’s TA Score has 4 bullish TA indicator(s).

  • ENOV’s TA Score: 5 bullish, 4 bearish.
  • SIBN’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, SIBN is a better buy in the short-term than ENOV.

Price Growth

ENOV (@Medical/Nursing Services) experienced а +1.35% price change this week, while SIBN (@Medical/Nursing Services) price change was +0.96% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +7.62%. For the same industry, the average monthly price growth was -1.16%, and the average quarterly price growth was -16.57%.

Reported Earning Dates

ENOV is expected to report earnings on Jul 30, 2026.

SIBN is expected to report earnings on Aug 10, 2026.

Industries' Descriptions

@Medical/Nursing Services (+7.62% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ENOV($1.51B) has a higher market cap than SIBN($791M). ENOV YTD gains are higher at: -1.464 vs. SIBN (-9.483). SIBN has higher annual earnings (EBITDA): -8.03M vs. ENOV (-770.33M). SIBN has more cash in the bank: 145M vs. ENOV (33.1M). SIBN has less debt than ENOV: SIBN (42.9M) vs ENOV (1.41B). ENOV has higher revenues than SIBN: ENOV (2.28B) vs SIBN (206M).
ENOVSIBNENOV / SIBN
Capitalization1.51B791M191%
EBITDA-770.33M-8.03M9,594%
Gain YTD-1.464-9.48315%
P/E RatioN/AN/A-
Revenue2.28B206M1,106%
Total Cash33.1M145M23%
Total Debt1.41B42.9M3,289%
FUNDAMENTALS RATINGS
ENOV vs SIBN: Fundamental Ratings
ENOV
SIBN
OUTLOOK RATING
1..100
1320
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
36
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9995
PRICE GROWTH RATING
1..100
5244
P/E GROWTH RATING
1..100
98100
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SIBN's Valuation (36) in the Medical Specialties industry is somewhat better than the same rating for ENOV (76) in the Industrial Machinery industry. This means that SIBN’s stock grew somewhat faster than ENOV’s over the last 12 months.

SIBN's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as ENOV (100) in the Industrial Machinery industry. This means that SIBN’s stock grew similarly to ENOV’s over the last 12 months.

SIBN's SMR Rating (95) in the Medical Specialties industry is in the same range as ENOV (99) in the Industrial Machinery industry. This means that SIBN’s stock grew similarly to ENOV’s over the last 12 months.

SIBN's Price Growth Rating (44) in the Medical Specialties industry is in the same range as ENOV (52) in the Industrial Machinery industry. This means that SIBN’s stock grew similarly to ENOV’s over the last 12 months.

ENOV's P/E Growth Rating (98) in the Industrial Machinery industry is in the same range as SIBN (100) in the Medical Specialties industry. This means that ENOV’s stock grew similarly to SIBN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ENOVSIBN
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
80%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 1 day ago
85%
Momentum
ODDS (%)
Bullish Trend 1 day ago
57%
Bullish Trend 6 days ago
70%
MACD
ODDS (%)
Bullish Trend 1 day ago
66%
Bullish Trend 5 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
65%
Bullish Trend 1 day ago
75%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
60%
Bullish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 1 day ago
61%
Bullish Trend 1 day ago
75%
Declines
ODDS (%)
Bearish Trend 6 days ago
78%
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
69%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
67%
Bullish Trend 1 day ago
68%
View a ticker or compare two or three
Interact to see
Advertisement
ENOV
Daily Signal:
Gain/Loss:
SIBN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GCIEX6.78N/A
N/A
Gabelli Equity Income I
NQVCX66.78N/A
N/A
Nuveen Multi Cap Value C
PRWCX38.43N/A
N/A
T. Rowe Price Capital Appreciation
SVFFX95.89N/A
N/A
Smead Value I1
VIDGX12.21N/A
N/A
Vanguard International Dividend Gr Inv

ENOV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENOV has been loosely correlated with CNMD. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ENOV jumps, then CNMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENOV
1D Price
Change %
ENOV100%
+1.94%
CNMD - ENOV
58%
Loosely correlated
+10.21%
FELE - ENOV
56%
Loosely correlated
-0.41%
DOV - ENOV
55%
Loosely correlated
-0.49%
PH - ENOV
53%
Loosely correlated
-1.04%
ITT - ENOV
52%
Loosely correlated
-0.26%
More

SIBN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SIBN has been loosely correlated with ATEC. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if SIBN jumps, then ATEC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SIBN
1D Price
Change %
SIBN100%
+1.65%
ATEC - SIBN
46%
Loosely correlated
+1.67%
ATRC - SIBN
40%
Loosely correlated
+1.52%
PODD - SIBN
40%
Loosely correlated
+0.48%
EW - SIBN
40%
Loosely correlated
-0.46%
ENOV - SIBN
39%
Loosely correlated
+1.94%
More